Arterial Study Tour | July: Decode the Origins of Precision Medicine Innovation in the U.S.

Precision medicine has emerged as a disruptive force, heralding “a new era in medicine.” In 2018, precision medicine entered a favorable period of development, with the United States standing out as one of the global hotspots for precision medicine companies, boasting unparalleled advantages in cutting-edge technology and innovative management systems.

Timing is the most critical element of investment. This July, VCBeat and Health Intelligence Valley are jointly launching a U.S. Precision Medicine Innovation Study Tour, inviting you to travel to the United States to engage in dialogues with top global scientists and corporate executives, and to explore the core essence and origins of innovation in precision medicine.

United States: It Will Be Too Late If You Don’t Act Now

1. A Market Worth Hundreds of Billions:The global market size for precision medicine has surpassed $60 billion. Over the next five years, it is projected to grow at an annual rate of 15% worldwide, while China’s growth rate will exceed 20%, evolving into a market valued at hundreds of billions of yuan.

2. Frontier of Core Technologies:The United States leads the frontier of core precision medicine technologies, such as gene sequencing and cell therapy. Currently, the world’s most highly valued precision medicine companies and the largest number of publicly listed firms in this sector are all based in the United States.

3. Capital Preference:In the first three months of 2018, Chinese venture capital funds invested $1.4 billion in U.S. private biotechnology companies, accounting for approximately 40% of the total $3.7 billion raised by these companies during the same period.

Shanda Group has invested $36 million in Community Health Systems (CHS).

Sanpower Group Acquires Dendreon, a Renowned Global Biopharmaceutical Company, for $819 Million

Wandong Medical Announces $1.931 Billion Overseas Acquisition.

Also Fosun, CITIC, Sequoia, Hillhouse, Evergrande...

Invite friends to go to the United States,

Embark on a “cutting-edge” exploration of precision medicine!

3 Core Cities, Converging the World’s Leading Medical Institutions and Enterprises

New York——Home to NYC Health + Hospitals, the largest public healthcare system in the United States, and Memorial Sloan Kettering Cancer Center, the world’s largest private cancer center and one of the key sites visited during this trip.

Boston—With a focus on biotechnology, life sciences, and pharmaceuticals, Boston is home to numerous renowned hospitals, including Massachusetts General Hospital (MGH), which will be a key site for visits and exchanges during this study tour.

San Francisco——Maintains a global leading position in medical imaging, information technology, medical diagnostics and disease research, drug development, and biopharmaceutical production technologies.

Three Core Themes, Delving Deeper Layer by Layer to Strike at the Heart of Precision Medicine Innovation and Entrepreneurship in the United States

Technological Innovation: Visit the MIT laboratory of Academician Feng Zhang, which focuses on gene editing, and BioChain, a gene sequencing company specializing in cancer therapy, to explore the world’s most cutting-edge gene-editing technologies and the logic behind the technological upgrades of leading enterprises.

Business Innovation: Visiting Plug and Play, Rock Health, Nest Bio, and TripleRing—tech enterprise incubators and accelerators dedicated to helping startup teams achieve rapid growth—to engage in discussions with early-stage startups on technological innovation and business model innovation.

Management Innovation: Step into Massachusetts General Hospital (MGH), ranked No. 1 among the best hospitals in the United States, and Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center, to explore the secrets of operational management at leading-edge medical institutions.

Dialogue with Professor Feng Zhang: Insights into the Composition of the Technological Innovation Value Chain

During this trip, we will visit the laboratory of Dr. Feng Zhang, an Academician at MIT, also known as the Feng Zhang Gene Editing Laboratory. Professor Zhang is one of the most prominent Chinese-American biologists today. He was among the first to secure U.S. patents for the development and application of CRISPR-Cas9 gene-editing technology and is considered a leading contender for the Nobel Prize.

In 2017, Professor Feng Zhang was promoted to tenured professor in the School of Science at the Massachusetts Institute of Technology (MIT) and received the Albany Medical Center Prize in Medicine and Biomedical Research, becoming the second Chinese scholar in history to receive this award. In 2018, he was elected as a member of the U.S. National Academy of Sciences.

Recently, Beam Therapeutics, a new company co-founded by Professor Feng Zhang, was officially launched.Beam is the world’s first innovative company to develop precision gene therapies using single-base editing technology, having recently secured $87 million in Series A financing.

Visit Harvard Medical School in Person and Experience the Academic Atmosphere of a Prestigious Institution

Harvard Medical School (HMS) is the top-ranked medical school in the United States, boasting world-leading medical experts and cutting-edge medical technology, and has produced 18 Nobel laureates in Physiology or Medicine to date.

Build a Vibrant Social Circle: Experience America’s Scenic Wonders with Heart and Footsteps

This study tour is not a cookie-cutter, assembly-line inspection trip, nor is it a superficial glance. With limited enrollment and access to high-level professional circles, it will help you build an effective network within eight days.Take a break from your study tour and embark on a self-driving adventure across America’s iconic cities with friends, immersing yourselves in the nation’s music, culture, art, history, and cuisine to discover unique surprises.

Eligibility Criteria:Limited seats available. Registration is open exclusively to executives from precision medicine companies, biotechnology firms, healthcare service providers, health informatics enterprises, and investment institutions.

Departure Time:July 28–August 4, 2018

CostsFangOption 1: Register and pay the deposit on or before June 15 for RMB 68,000

①Costs include: round-trip international airfare、All activity experiences, dining and transportation, hotel accommodations, overseas travel accident insurance, and team service fees during the visit

② Exclusions: Domestic transportation, accommodation and meals, visa application fees, personal optional activities, etc.

Option 2: RMB 60,000 for registrations after June 15

① The fee includes: all activity experiences during the visit, dining and transportation, hotel accommodation, overseas travel accident insurance, and team service fees.

②Costs Excluded: Round-trip International Airfare, domestic transportation and accommodation expenses, visa application fees, costs for optional personal activities, etc.

Service Standards:Accommodations in luxury hotels throughout the journey, featuring local gourmet cuisine, and supported by a team of multiple translators and experienced logistics staff.

For more details on the study tour, please scan the QR code below to fill out the information form or contact us by phone at 15208495425 (Ms. Fang).